PA83-FhCMB Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine

计划入组 30 人 · 首次发布于 2014 年 9 月 12 日

Trial to Evaluate the Safety and Immunogenicity of an Anthrax Recombinant Protective Antigen Vaccine

计划入组 100 人 · 首次发布于 2005 年 2 月 9 日

An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection

计划入组 20 人 · 首次发布于 2013 年 12 月 20 日

rPA-102

rPA-7909

Recombinant protective antigen vaccines (Pfenex)

ANTIGEN LABORATORIES INC.

United States

TTK HEALTHCARE LIMITED

India

PPG Industries

United States

South Korea Approves World's First Recombinant Anthrax Vaccine BARYTHRAX

NIAB Scientists Develop Next-Generation Leptospirosis Vaccine Strategy

GC Biopharma's BARYTHRAX Becomes World's First Recombinant Anthrax Vaccine to Show Protective Immunity in Phase 2 Trial